Daily pill helps keep weight off after stopping obesity jabs
In the US, where it is available, the price is cheaper than current injectables, at around $149 per month for…
Tag: obesity
UnitedHealth Sees ‘Challenges’ With Medicare Obesity Program
UnitedHealth Group Inc. sees difficulties with the Trump administration’s plan to cover obesity drugs in Medicare next year, casting doubt…
Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO
Kailera Therapeutics Inc. shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized…
Neurocrine wants to develop new obesity drugs. It’s reportedly nearing an acquisition to accelerate that move.
Soleno Therapeutics stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy…
Eli Lilly GLP-1 pill Foundayo approved for obesity
The U.S. Food and Drug Administration approved Eli Lilly‘s GLP-1 pill, the company said, a major milestone for the Indianapolis-based…
Lilly’s Obesity Pill Gets US Approval in Challenge to Novo
Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity…
Lilly’s $7.8 Billion Bet Takes It Beyond Obesity Into Sleep
Scooping up Centessa gives Lilly a foothold in narcolepsy and a promising new class of wakefulness drugs. www.bloomberg.com #Lillys #Billion #Bet…
Innovent Biologics Bullish on China Obesity Drug Outlook
Innovent Biologics has reported its first profit even as competition from weight-loss generics looms. Speaking exclusively to Bloomberg’s “The China…
Innovent Shares Jump on First Profit, Obesity Drug Momentum
Innovent Biologics Inc. shares saw their biggest gains in nearly five months, after the Chinese drugmaker posted its first annual…
Pfizer Secures China Rights to Obesity Drug in $495 Million Deal
Pfizer Inc. has acquired exclusive rights to commercialize an obesity therapy in China, strengthening its push into the fast-growing weight…